tirzepatide libido study and Testosterone 🚨 New Research Alert! 🚨

Clinical trial data found that people using 5-mg injections of tirzepatide lost about 15% of their weight after more than a year of treatment, on average

Ravussin E, Sanchez-Delgado G, Martin CK, et al

That is a common intermediate dose during the tirzepatide escalation protocol

Not on the door

KwikPen recommendations Eagle-eyed prescribers will have spotted the recommendation for use of a swab during the administration of tirzepatide

A recombinant human glucagon-like peptide (GLP)-1albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis